Navigation Links
Digitek Medication Recalled Due to Risk of Digitalis Toxicity
Date:8/18/2009

EDISON, N.J.,, Aug. 18 /PRNewswire/ -- Digitek Medication: Digitek (digoxin tablets) is a widely-used medication used to treat various heart conditions, such as abnormal heart rhythms (atrial fibrillation & atrial flutter), and heart failure. Digitek is a powerful drug, which is so potent that even a slight increase in dosage can be toxic or fatal.

If you or a loved one has suffered digitalis toxicity or symptoms associated with digitalis toxicity as a result of taking Digitek, you should contact Eichen Levinson & Crutchlow (http://www.eichenlevinson.com/) to evaluate your claim. You may be entitled to compensation for medical expenses, loss of wages, and pain and suffering. Eichen's Digitek attorneys are able to handle and litigate Digitek cases no matter where you live

Digitek Recall: Following repeated Food and Drug Administration (FDA) criticisms of its manufacturing processes, the pharmaceutical company, Actavis Totowa issued a Class I nationwide drug recall for all lots of Digitek (digoxin) on the grounds that some tablets may contain twice the approved level of the active ingredient. A Class I recall is the most dangerous type of FDA recall. Even though the drugs are sold under different brand names, they are essentially the same product with the same active ingredient. Therefore, the recall pertains to Digitek tablets (all strengths) distributed by Mylan Pharmaceuticals and sold under the label "Bertek", as well as Digitek distributed by UDL Laboratories, Inc. and sold under the label "UDL".

Digitalis Toxicity Signs & Symptoms may include the following:

  • Visual changes, for example
    • Halos or rings of light around objects
    • Seeing lights or bright spots
    • Changes in color perception
    • Blind spots in vision
    • Blurred vision
  • Confusion
  • Loss of appetite
  • Nausea, vomiting, diarrhea
  • Palpitations
  • Irregular Pulse
  • Decreased urine output
  • Excessive nighttime urination
  • Overall Swelling
  • Decreased consciousness
  • Difficulty breathing when lying down

To evaluate your Digitek claim, contact Eichen Levinson & Crutchlow, with offices located in Edison, New Jersey and Toms River, New Jersey, provides award-winning legal services in the tri-state area and nationally in matters involving catastrophic personal injury, mass torts, medical malpractice, class actions, and consumer fraud litigation.

    Contact: Angela McKillop
    Amckillop@eichenlevinson.com
    EichenLevinson .com
    Tel: (732) 777-0100
    Fax: (732) 248-8273


'/>"/>
SOURCE Eichen Levinson & Crutchlow, LLP
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. US Drug Watchdog Expands Its National Investigation Into The Drug Called Digitek, And Would Like To Talk To Possible Victims
2. National Class Action Filed Against Manufacturer of Digitek(R) (Prescription Drug) in Federal Court in Michigan
3. Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity
4. Hissey Kientz, LLP Announces the Launch of Digitek Recall Help Web Site
5. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
6. Manic phase of bipolar disorder benefits from breast cancer medication
7. AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications
8. Mayo Clinic study indicates medication for ADHD may help student outcomes
9. Diet and medications may assist prevention of prostate cancer
10. Delmarva Foundation Implements Medication Therapy Management Program in Maryland and DC
11. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/12/2017)... Del. (PRWEB) , ... October 12, 2017 , ... ... and advisory services for healthcare compliance program management, will showcase a range of ... National Association for Assisted Living (NCAL) Convention and Expo to be held October ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized health ... expanded their existing home health joint venture through an agreement, effective October 1, ... joint venture home health company with Asante, delivering clinically integrated care, for the ...
(Date:10/12/2017)... ... 2017 , ... HMP , a leader in healthcare events and education, today ... Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & ... award competition recognizes editorial and design excellence across a range of sectors. This year’s ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 West ... in innovative solutions for injectable drug administration, today announced ... the market opens on Thursday, October 26, 2017, and ... results and business expectations at 9:00 a.m. Eastern Time. ... or 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)...  True Health, a leader in integrated diagnostics ... National Breast Cancer Awareness month to educate doctors ... Research recently published in ... than 10 million American women are at significant ... BRCA2 and have not had testing. These mutations can ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
Breaking Medicine Technology: